Item Type | Name |
Academic Article
|
Primitive hemopoietic stem cells: direct assay of most productive populations by competitive repopulation with simple binomial, correlation and covariance calculations.
|
Academic Article
|
High-resolution cell cycle analysis of defined phenotypic subsets within primitive human hematopoietic cell populations.
|
Academic Article
|
Relative to adult marrow, fetal liver repopulates nearly five times more effectively long-term than short-term.
|
Academic Article
|
Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors.
|
Academic Article
|
Recent progress in identifying genes regulating hematopoietic stem cell function and fate.
|
Academic Article
|
The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells.
|
Academic Article
|
Transduction of primitive human hematopoietic cells with recombinant adenovirus vectors.
|
Academic Article
|
A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations.
|
Academic Article
|
The return of clonal marking sheds new light on human hematopoietic stem cells.
|
Academic Article
|
The use of adenoviral vectors for genetic manipulation and analysis of primitive hematopoietic cells.
|
Academic Article
|
Adenovirus vectors for gene transduction into mobilized blood CD34+ cells.
|
Academic Article
|
Considerations for targeting malignant stem cells in leukemia.
|
Academic Article
|
Cancer stem cell biology: from leukemia to solid tumors.
|
Academic Article
|
Differential outcomes of human cytomegalovirus infection in primitive hematopoietic cell subpopulations.
|
Academic Article
|
Clonal and systemic analysis of long-term hematopoiesis in the mouse.
|
Academic Article
|
Feverfew: weeding out the root of leukaemia.
|
Academic Article
|
The potential of targeting malignant stem cells as a treatment for leukemia.
|
Academic Article
|
Parathyroid hormone stimulates expression of the Notch ligand Jagged1 in osteoblastic cells.
|
Academic Article
|
Searching for leukemia stem cells--not yet the end of the road?
|
Academic Article
|
The leukemic stem cell.
|
Academic Article
|
Rapid and selective death of leukemia stem and progenitor cells induced by the compound 4-benzyl, 2-methyl, 1,2,4-thiadiazolidine, 3,5 dione (TDZD-8).
|
Academic Article
|
Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data.
|
Academic Article
|
The biologic properties of leukemias arising from BCR/ABL-mediated transformation vary as a function of developmental origin and activity of the p19ARF gene.
|
Academic Article
|
Cancer stem cells: controversial or just misunderstood?
|
Academic Article
|
The increasing complexity of the cancer stem cell paradigm.
|
Academic Article
|
Radiation Therapy Oncology Group translational research program stem cell symposium: incorporating stem cell hypotheses into clinical trials.
|
Academic Article
|
NCI first International Workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on the biological considerations of hematological relapse following allogeneic stem cell transplantation unrelated to graft-versus-tumor effects: state of the science.
|
Academic Article
|
A novel in vitro assay of tumor-initiating cells in xenograft prostate tumors.
|
Academic Article
|
Leukemia stem cells and microenvironment: biology and therapeutic targeting.
|
Academic Article
|
Melampomagnolide B: a new antileukemic sesquiterpene.
|
Academic Article
|
Isolation and characterization of primitive hematopoietic cells based on their position in the cell cycle.
|
Academic Article
|
Expression of tumor-suppressor genes interferon regulatory factor 1 and death-associated protein kinase in primitive acute myelogenous leukemia cells.
|
Academic Article
|
Proteasome inhibition in myelodysplastic syndromes and acute myelogenous leukemia cell lines.
|
Academic Article
|
Functional inhibition of osteoblastic cells in an in vivo mouse model of myeloid leukemia.
|
Academic Article
|
Noncanonical NF-?B signaling regulates hematopoietic stem cell self-renewal and microenvironment interactions.
|
Academic Article
|
A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit.
|
Academic Article
|
Gene sets identified with oncogene cooperativity analysis regulate in vivo growth and survival of leukemia stem cells.
|
Academic Article
|
Long-term repopulating abilities of enriched fetal liver stem cells measured by competitive repopulation.
|
Academic Article
|
Cellular and molecular characterization of the role of the flk-2/flt-3 receptor tyrosine kinase in hematopoietic stem cells.
|
Academic Article
|
The hematopoietic stem cell in myelodysplasia.
|
Academic Article
|
The level of mRNA encoding the amphotropic retrovirus receptor in mouse and human hematopoietic stem cells is low and correlates with the efficiency of retrovirus transduction.
|
Academic Article
|
Eukaryotic translation initiation factor 4E activity is modulated by HOXA9 at multiple levels.
|
Academic Article
|
Cellular and developmental properties of fetal hematopoietic stem cells.
|
Academic Article
|
Transduction efficiency of cell lines and hematopoietic stem cells correlates with retrovirus receptor mRNA levels.
|
Academic Article
|
Targeting the most critical cells: approaching leukemia therapy as a problem in stem cell biology.
|
Academic Article
|
Efficient and durable gene marking of hematopoietic progenitor cells in nonhuman primates after nonablative conditioning.
|
Academic Article
|
Genetic manipulation of primitive leukemic and normal hematopoietic cells using a novel method of adenovirus-mediated gene transfer.
|
Academic Article
|
Mechanisms controlling pathogenesis and survival of leukemic stem cells.
|
Academic Article
|
The molecular basis of leukemia.
|
Academic Article
|
The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells.
|
Academic Article
|
An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells.
|
Academic Article
|
The NF-kappaB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target.
|
Academic Article
|
Cancer stem cells.
|
Academic Article
|
Can we finally target the leukemic stem cells?
|
Academic Article
|
Lessons learned from the study of JunB: new insights for normal and leukemia stem cell biology.
|
Academic Article
|
Leukemia stem cells in a genetically defined murine model of blast-crisis CML.
|
Academic Article
|
Protein kinase C-associated kinase is required for NF-kappaB signaling and survival in diffuse large B-cell lymphoma cells.
|
Academic Article
|
Targeting myeloid leukemia stem cells.
|
Academic Article
|
High-risk acute lymphoblastic leukemia cells with bcr-abl and INK4A/ARF mutations retain susceptibility to alloreactive T cells.
|
Academic Article
|
In vivo prostaglandin E2 treatment alters the bone marrow microenvironment and preferentially expands short-term hematopoietic stem cells.
|
Academic Article
|
The NF (Nuclear factor)-?B inhibitor parthenolide interacts with histone deacetylase inhibitors to induce MKK7/JNK1-dependent apoptosis in human acute myeloid leukaemia cells.
|
Academic Article
|
Chemical genomic screening reveals synergism between parthenolide and inhibitors of the PI-3 kinase and mTOR pathways.
|
Academic Article
|
Leukemia stem cells in 2010: current understanding and future directions.
|
Academic Article
|
Discovery of 1,2,4-thiadiazolidine-3,5-dione analogs that exhibit unusual and selective rapid cell death kinetics against acute myelogenous leukemia cells in culture.
|
Academic Article
|
Leukemia stemness signatures step toward the clinic.
|
Academic Article
|
How close are we to targeting the leukemia stem cell?
|
Academic Article
|
BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells.
|
Concept
|
Hematopoietic Stem Cells
|
Concept
|
Lymphocytes
|
Concept
|
T-Lymphocytes, Cytotoxic
|
Concept
|
Neoplastic Stem Cells
|
Concept
|
HeLa Cells
|
Concept
|
CD8-Positive T-Lymphocytes
|
Concept
|
Clone Cells
|
Concept
|
Myeloid Progenitor Cells
|
Concept
|
K562 Cells
|
Concept
|
Dendritic Cells
|
Concept
|
Granulocyte Precursor Cells
|
Concept
|
Neoplastic Cells, Circulating
|
Concept
|
CD4-Positive T-Lymphocytes
|
Concept
|
Stromal Cells
|
Concept
|
B-Lymphocytes
|
Concept
|
3T3 Cells
|
Concept
|
Tumor Cells, Cultured
|
Concept
|
Lymphoid Progenitor Cells
|
Concept
|
Bone Marrow Cells
|
Concept
|
Myeloid Cells
|
Concept
|
Killer Cells, Natural
|
Concept
|
Cells, Cultured
|
Concept
|
Stem Cells
|
Concept
|
T-Lymphocytes
|
Academic Article
|
In Vivo RNAi screening identifies a leukemia-specific dependence on integrin beta 3 signaling.
|
Academic Article
|
Targeting aberrant glutathione metabolism to eradicate human acute myelogenous leukemia cells.
|
Academic Article
|
Therapeutic antagonists of microRNAs deplete leukemia-initiating cell activity.
|
Academic Article
|
Discovery of potent parthenolide-based antileukemic agents enabled by late-stage P450-mediated C-H functionalization.
|
Academic Article
|
Metabolic effects of acute thiamine depletion are reversed by rapamycin in breast and leukemia cells.
|
Academic Article
|
Aldehyde dehydrogenases in acute myeloid leukemia.
|
Academic Article
|
Selenium suppresses leukemia through the action of endogenous eicosanoids.
|
Academic Article
|
Selective activity of the histone deacetylase inhibitor AR-42 against leukemia stem cells: a novel potential strategy in acute myelogenous leukemia.
|
Academic Article
|
Protein kinase C-associated kinase regulates NF-?B activation through inducing IKK activation.
|
Academic Article
|
Targeting acute myeloid leukemia stem cells: a review and principles for the development of clinical trials.
|
Academic Article
|
Flavaglines target primitive leukemia cells and enhance anti-leukemia drug activity.
|
Academic Article
|
Efficacy of a Mer and Flt3 tyrosine kinase small molecule inhibitor, UNC1666, in acute myeloid leukemia.
|
Academic Article
|
Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics.
|
Academic Article
|
Dimers of Melampomagnolide B Exhibit Potent Anticancer Activity against Hematological and Solid Tumor Cells.
|
Academic Article
|
Acute myeloid leukaemia.
|
Academic Article
|
Leukemic Stem Cells Evade Chemotherapy by Metabolic Adaptation to an Adipose Tissue Niche.
|
Academic Article
|
Evolution of acute myelogenous leukemia stem cell properties after treatment and progression.
|
Academic Article
|
Rational Design of a Parthenolide-based Drug Regimen That Selectively Eradicates Acute Myelogenous Leukemia Stem Cells.
|
Academic Article
|
Rational design of a parthenolide-based drug regimen that selectively eradicates acute myelogenous leukemia stem cells.
|
Academic Article
|
Identification of a melampomagnolide B analog as a potential lead molecule for treatment of acute myelogenous leukemia.
|
Academic Article
|
Therapeutic targeting of acute myeloid leukemia stem cells.
|
Academic Article
|
Targeted therapy for a subset of acute myeloid leukemias that lack expression of aldehyde dehydrogenase 1A1.
|
Grant
|
Cellular and Molecular Studies of Leukemic Stem Cellss
|
Grant
|
Oncogene Cooperativity in Leukemia Stem Cells
|
Grant
|
Amnis ImageStream Flow Cytometer
|
Grant
|
Selective in vivo Ablation of Leukemia Stem Cells
|
Grant
|
Characterization and targeting of leukemia stem cell metabolism
|
Academic Article
|
Indole carboxylic acid esters of melampomagnolide B are potent anticancer agents against both hematological and solid tumor cells.
|
Grant
|
Microenvironment-induced metabolic plasticity in leukemia stem cells
|
Academic Article
|
Micelle Delivery of Parthenolide to Acute Myeloid Leukemia Cells.
|
Academic Article
|
AMPK/FIS1-Mediated Mitophagy Is Required for Self-Renewal of Human AML Stem Cells.
|
Academic Article
|
MMB triazole analogs are potent NF-?B inhibitors and anti-cancer agents against both hematological and solid tumor cells.
|
Academic Article
|
Characterization and targeting of malignant stem cells in patients with advanced myelodysplastic syndromes.
|
Academic Article
|
Subversion of Systemic Glucose Metabolism as a Mechanism to Support the Growth of Leukemia Cells.
|
Academic Article
|
MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunity.
|
Academic Article
|
Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia.
|
Academic Article
|
Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells.
|
Academic Article
|
Why are hypomethylating agents or low-dose cytarabine and venetoclax so effective?
|
Academic Article
|
Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells.
|
Academic Article
|
Myelodysplastic syndrome-associated spliceosome gene mutations enhance innate immune signaling.
|
Concept
|
MCF-7 Cells
|
Concept
|
HEK293 Cells
|
Concept
|
RAW 264.7 Cells
|
Academic Article
|
The Hematopoietic Oxidase NOX2 Regulates Self-Renewal of Leukemic Stem Cells.
|
Academic Article
|
Cysteine depletion targets leukemia stem cells through inhibition of electron transport complex II.
|
Academic Article
|
CD123 CAR T cells for the treatment of myelodysplastic syndrome.
|
Grant
|
Therapeutic Targeting of MDS Stem Cells
|
Academic Article
|
Can we selectively target AML stem cells?
|
Grant
|
Metabolic mechanisms of venetoclax resistance in acute myeloid leukemia stem cells
|
Academic Article
|
Substituted oxindol-3-ylidenes as AMP-activated protein kinase (AMPK) inhibitors.
|
Academic Article
|
Delivery of a model lipophilic membrane cargo to bone marrow via cell-derived microparticles.
|
Academic Article
|
Nicotinamide Metabolism Mediates Resistance to Venetoclax in Relapsed Acute Myeloid Leukemia Stem Cells.
|
Academic Article
|
The Hepatic Microenvironment Uniquely Protects Leukemia Cells through Induction of Growth and Survival Pathways Mediated by LIPG.
|
Grant
|
Therapeutic Targeting of Human AML Stem Cells
|
Academic Article
|
MDS-associated SF3B1 mutations enhance proinflammatory gene expression in patient blast cells.
|
Academic Article
|
Exploiting Protein Translation Dependence in Multiple Myeloma with Omacetaxine-Based Therapy.
|
Academic Article
|
Enriching for human acute myeloid leukemia stem cells using reactive oxygen species-based cell sorting.
|
Academic Article
|
Targeting Energy Metabolism in Cancer Stem Cells: Progress and Challenges in Leukemia and Solid Tumors.
|
Academic Article
|
PU.1 enforces quiescence and limits hematopoietic stem cell expansion during inflammatory stress.
|
Academic Article
|
Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells.
|
Academic Article
|
Comprehensive Structure-Activity Profiling of Micheliolide and its Targeted Proteome in Leukemia Cells via Probe-Guided Late-Stage C-H Functionalization.
|
Academic Article
|
The STAT3-MYC axis promotes survival of leukemia stem cells by regulating SLC1A5 and oxidative phosphorylation.
|
Academic Article
|
Therapeutic resistance in acute myeloid leukemia cells is mediated by a novel ATM/mTOR pathway regulating oxidative phosphorylation.
|
Academic Article
|
HSF1 is a driver of leukemia stem cell self-renewal in acute myeloid leukemia.
|
Academic Article
|
Therapy-Resistant Acute Myeloid Leukemia Stem Cells Are Resensitized to Venetoclax + Azacitidine by Targeting Fatty Acid Desaturases 1 and 2.
|
Academic Article
|
A Novel Type of Monocytic Leukemia Stem Cell Revealed by the Clinical Use of Venetoclax-Based Therapy.
|
Academic Article
|
Targeting Acute Myeloid Leukemia Stem Cells Through Perturbation of Mitochondrial Calcium.
|
Grant
|
Targeting mitochondrial calcium to eradicate leukemia-initiating cells
|